SCHEMBL8501217

SCHEMBL8501217

CC(Sc1cccc(NC(=N)N)c1)c1cccc(C(CC(=O)O)c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 13/20 0.45
ITGAV P06756 13/20 0.45
ITGA2B P08514 10/20 0.45
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
CBLB Q13191 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8501227 0.84 ITGB3 (0.40) ITGB3ITGAVITGA2BCBLB
SCHEMBL7864761 0.81 ITGB3 (0.43) ITGB3ITGAVITGA2BMEN1KMT2A
SCHEMBL8501220 0.80 ITGB3 (0.42) ITGB3ITGAVITGA2BMEN1KMT2A
SCHEMBL7863285 0.78 ITGB3 (0.48) ITGB3ITGAVITGA2BALDH1A1HPGD
SCHEMBL8535992 0.77 ITGB3 (0.40) ITGB3ITGAVITGA2BMEN1KMT2A
SCHEMBL7856431 0.77 HDAC1 (0.45) ITGB3ITGA2BALDH1A1HPGDMEN1
SCHEMBL7856433 0.77 ITGB3 (0.54) ITGB3ITGA2BMEN1KMT2APOLB
SCHEMBL7861944 0.77 HDAC1 (0.45) ITGB3ITGA2BALDH1A1HPGDMEN1
SCHEMBL7864754 0.77 PTPN11 (0.48) ITGB3ITGAVITGA2BALDH1A1HPGD
SCHEMBL2837207 0.76 ITGB3 (0.61) ITGB3ITGAVITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889877-A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS G.D. SEARLE & CO. (US) 1999-01-13 EP disclosed
WO-1997036862-A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS G.D. SEARLE & CO. (US) 1997-10-09 WO disclosed